comprehensive -WSS

comprehensive

author：hotspot 2025-09-03 03:24:14 - browse：47381

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： How the drug

WSS

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Trans patients at the end of life deserve respect and dignity

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Former Pear Therapeutics executives start new VC firm

How the drug

hotspot

comprehensive

hotspot

Bright Health sells Medicare Advantage business to Molina

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Walensky prepares to leave CDC — and Congress — behind

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UPS workers' union leader explains what's at stake as strike edges closer

Dobbs anniversary: the lost opportunity of abortion as health care

Sen. Bill Cassidy on how to lower drug prices

Continuity nursing helped my family in our darkest PICU moments

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

explore

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Study: Spinal cord stimulation helps patients with paralysis walk again

House panel to mark up pandemic

FDA greenlights medical device to combat bladder issues

Meadows told special counsel he could not recall Trump ever declassifying Mar

Former Pear Therapeutics executives start new VC firm

explore

knowledge

Wikipedia

hotspot